Zobrazeno 1 - 10
of 249
pro vyhledávání: '"Camelliti P"'
Publikováno v:
Advanced Science, Vol 11, Iss 32, Pp n/a-n/a (2024)
Abstract Cell therapy is a potential novel treatment for cardiac regeneration and numerous studies have attempted to transplant cells to regenerate the myocardium lost during myocardial infarction. To date, only minimal improvements to cardiac functi
Externí odkaz:
https://doaj.org/article/2e886730de8d4680b41bdbf2cf680658
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Living heart slices have recently emerged as a powerful experimental model for fundamental cardiac research. By retaining the structure and function of the native myocardium while maintaining the simplicity of cell culture models, heart slices can be
Externí odkaz:
https://doaj.org/article/1ac636cf22f64001a5c033c41252f2c9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Brett C Baggett, Kevin R Murphy, Elif Sengun, Eric Mi, Yueming Cao, Nilufer N Turan, Yichun Lu, Lorraine Schofield, Tae Yun Kim, Anatoli Y Kabakov, Peter Bronk, Zhilin Qu, Patrizia Camelliti, Patrycja Dubielecka, Dmitry Terentyev, Federica del Monte, Bum-Rak Choi, John Sedivy, Gideon Koren
Publikováno v:
eLife, Vol 12 (2023)
Progressive tissue remodeling after myocardial infarction (MI) promotes cardiac arrhythmias. This process is well studied in young animals, but little is known about pro-arrhythmic changes in aged animals. Senescent cells accumulate with age and acce
Externí odkaz:
https://doaj.org/article/d202d60827684d86801b098db8759f70
Autor:
Qin Wu, Abigail J. Ross, Tugce Ipek, Georgina H. Thompson, Robert D. Johnson, Changhao Wu, Patrizia Camelliti
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced a
Externí odkaz:
https://doaj.org/article/b6da9934a8844a17b964cae91e0b70e9
Publikováno v:
npj Regenerative Medicine, Vol 7, Iss 1, Pp 1-16 (2022)
Abstract The epicardium constitutes an untapped reservoir for cardiac regeneration. Upon heart injury, the adult epicardium re-activates, leading to epithelial-to-mesenchymal transition (EMT), migration, and differentiation. While interesting mechani
Externí odkaz:
https://doaj.org/article/4af0c1ce8c524f00b458b89c3565dc5b
Autor:
Davide Maselli, Rolando S. Matos, Robert D. Johnson, Davide Martella, Valeria Caprettini, Ciro Chiappini, Patrizia Camelliti, Paola Campagnolo
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
The epicardium has recently gained interest in the cardiovascular field due to its capacity to support heart regeneration after ischemic injury. Models to study the epicardium of large animals in vitro are limited and mainly based on epicardial cell
Externí odkaz:
https://doaj.org/article/60061df1448d4413901386913aa7949c
Publikováno v:
Continence, Vol 2, Iss , Pp 1- (2022)
Externí odkaz:
https://doaj.org/article/d98f88fba42944b29c3d0e9e50f4034a
Autor:
Federica Cossu, Simone Camelliti, Daniele Lecis, Luca Sorrentino, Maria Teresa Majorini, Mario Milani, Eloise Mastrangelo
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 19, Iss , Pp 6366-6374 (2021)
Inhibitors of apoptosis proteins (IAPs) are validated onco-targets, as their overexpression correlates with cancer onset, progression, diffusion and chemoresistance. IAPs regulate cell death survival pathways, inflammation, and immunity. Targeting IA
Externí odkaz:
https://doaj.org/article/c86117b4d2eb46419e5f2244e91de453
Autor:
Simone Camelliti, Valentino Le Noci, Francesca Bianchi, Claudia Moscheni, Francesca Arnaboldi, Nicoletta Gagliano, Andrea Balsari, Marina Chiara Garassino, Elda Tagliabue, Lucia Sfondrini, Michele Sommariva
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-20 (2020)
Abstract Immune checkpoint inhibitors (ICIs) have made a breakthrough in the treatment of different types of tumors, leading to improvement in survival, even in patients with advanced cancers. Despite the good clinical results, a certain percentage o
Externí odkaz:
https://doaj.org/article/4d7400b9bbc24ac089902f2f0ec236ff